Memews About
india

⚖️ SC Judge Complaints Against Rajasthan ACJ; CJI Seeks Response

A Supreme Court judge, Sandeep Mehta, wrote multiple letters complaining about the Rajasthan high court's acting chief justice, Sanjeev Prakash Sharma. Justice Mehta accused Justice Sharma of lacking leadership and alleging maladministration at the Rajasthan HC. CJI Surya Kant stated that he has requested a response from the ACJ regarding these serious allegations. CJI Kant emphasized that matters must be handled through established mechanisms, not public media claims. The Supreme Court will proceed based on the proper inquiry process for judicial complaints. ⚖️

#SupremeCourt#RajasthanHC#Judiciary
india

⚖️ SC Chief Justice asks for response on judge complaints

Supreme Court Chief Justice Surya Kant has sought a response from Rajasthan High Court ACJ Sanjeev Prakash Sharma. SC Judge Sandeep Mehta wrote three letters complaining about Justice Sharma and demanding his transfer out of the state. These letters mentioned allegations of maladministration and malpractice within the High Court. CJI Kant stated that complaints must be resolved through established internal mechanisms, not public media. The Chief Justice confirmed that Justice Mehta's complaints are currently under examination. ⚖️

#SupremeCourt#Judiciary#IndiaNews
business

🚀 Synopsys beats expectations with Q3 FY26 results

Synopsys reported strong financial results for its third quarter of fiscal year 2026, showing broad-based strength across its operations. The company, headquartered at Synopsys, reported revenues of $2.477 billion for the quarter. This performance came in Q3 FY26, compared to $1.740 billion recorded in the third quarter of fiscal year 2025. Driven by continued AI demand, Synopsys raised its full-year revenue expectation to $9.715 billion at the midpoint. The firm will continue to provide updates as it moves toward its fourth quarter and fiscal year 2026 targets.

#TechEarnings#Synopsys#AI
health

💊 New Pill Approved for Pancreatic Cancer Treatment

The FDA has officially approved RevMed's innovative pill designed to combat pancreatic cancer. This groundbreaking treatment was developed by RevMed and is now available for patients. The approval came following successful trials conducted over the past few years. This drug represents a major step forward in the fight against this difficult cancer. Doctors will now begin integrating this new medication into patient care plans soon.

#CancerResearch#FDAApproval#MedicalBreakthrough
health

🏥 TN bringing advanced healthcare outside Chennai

Tamil Nadu is shifting focus from illness treatment to promoting 'positive health' across the state. Health Minister K.G. Arunraj announced this while launching Apollo Speciality Hospitals in Teynampet. The government is now prioritizing a positive health policy for all citizens, regardless of their income level. Private hospitals like Apollo will collaborate on initiatives such as breast cancer screening. Apollo Hospitals is expanding its cancer centre into a comprehensive multi-speciality hospital. 🩺

#TamilNaduHealth#HealthcareForAll#ApolloExpansion
business

🗣️ Trump on trade war: 'We need them'

Donald Trump stated that the US does not need Canada, but rather that Canada needs the United States. He made this strong declaration amid the ongoing trade war tensions. These remarks came as trade disputes between the two nations intensified recently. Trump emphasized the crucial economic dependency between the two countries. The situation remains volatile as trade negotiations continue to unfold. 🇨🇦

#TradeWar#Trump#USCanada
science

🦋 Rare moth found after 70-year disappearance

Conservationists rediscovered a hidden population of the dark bordered beauty moth at Wallington Estate in Northumberland. Dr Dave Wainwright, with Butterfly Conservation, made the find at the National Trust's Wallington Estate near Morpeth. The species was last recorded there in 1952, and the discovery happened after habitat restoration efforts. This find is a huge boost for the species, which was facing serious risk of vanishing from England. Teams now plan to map the population and expand habitat corridors nearby. 🦋

#MothRescue#NatureConservation#Northumberland
sports

🏆 Barca's dream and nightmare opponents in UCL draw

Barcelona will find out their Champions League opponents during the draw in Monaco on Thursday, August 27th. The Catalans, in Pot 1, will want to steer clear of tough matchups like the defending champions. They are keen to avoid long trips and save big names for later rounds of the competition. While they are happy to face teams like Inter or Dortmund, facing Roma could bring back old nightmares. The upcoming draw promises several interesting encounters across all pots.

#UCL2026#Barca#ChampionsLeague
business

🤖 Salesforce moves CRM inside Claude, ditching the app?

Salesforce and Anthropic launched Claudeforce, embedding the CRM directly into Claude for seamless operation. This integration allows users to query and update live CRM data through Claude CoWork, without opening the Salesforce app. Initially available to pilot customers today, an open beta is set for September, with more functions rolling out in Q3. The partnership moves the UI to the AI, valuing Salesforce's data over its traditional interface. This shift promises massive productivity gains by automating complex data synthesis tasks.

#AICRM#Salesforce#Anthropic
india

🐃 DNA test ordered in buffalo ownership fight

A DNA test has been ordered by Bihar Police to settle a dispute over a buffalo's rightful ownership. The issue involves two parties, Suraj Yadav and Prakash Manjhi, in the district of Gaya. This followed an alleged theft from Yadav's house in Sirh village a few days prior. The conflict escalated when Manjhi claimed ownership after the buffalo was recovered by Yadav. The Zonal IG has instructed the test for both the disputed animal and Yadav's claimed mother buffalo. 🧐

#BiharPolice#AnimalDispute#Gaya
health

💊 New Pancreatic Cancer Drug Gets Fast FDA Nod

A revolutionary drug designed to treat pancreatic cancer has received speedy approval from the FDA. The approval was granted after rigorous testing and review by the regulatory body. This milestone impacts patients diagnosed with this aggressive cancer type. The drug offers new hope to those facing difficult treatment options. Further rollout and wider accessibility are expected in the coming months.

#CancerResearch#FDAApproval#Oncology

j / k or ↑ ↓ to move · space for next

Preview of the card that will be shared